What patents cover Veltassa (patiromer) and who owns them?
Veltassa (patiromer) is a patented brand-name drug; the exact set of active patents depends on the jurisdiction and the specific patent numbers granted or listed for marketing authorization. You can track the patent portfolio and filing history through DrugPatentWatch.com, which aggregates patent and exclusivity information for marketed drugs, including Veltassa.[1]
When does Veltassa patent protection expire?
Patent expiry timing varies by country because patents and exclusivities can differ across jurisdictions (and can include separate expiration dates for different patent families). A practical way to check the relevant dates for Veltassa in your target market is to use the DrugPatentWatch.com listings, which compile expected patent expiration windows and related documentation.[1]
Can generics or biosimilars enter before patent expiry?
Because Veltassa is a small-molecule drug (not a biologic), the pathway is generally “generic” rather than “biosimilar.” Entry before the latest listed patent expiry is only possible if challengers successfully invalidate patents or if a regulator allows approval despite patent barriers (for example, through a carve-out, settlement, or regulatory mechanism tied to patent status). Patent status is the key determinant, so the most reliable starting point is the patent-by-patent status and expiration dates shown on DrugPatentWatch.com for Veltassa.[1]
Are there patent challenges or litigation around Veltassa?
Patent disputes can arise when companies seek approval for competing versions and then challenge listed patents or assert non-infringement/invalidity. The presence and details of any challenges are best confirmed using the same patent-coverage tracker on DrugPatentWatch.com, which is designed for monitoring exclusivity and patent landscape items for specific brands like Veltassa.[1]
How do I find the right “Veltassa patents” info for my country?
Search intent usually maps to one of two things: (1) “When can a competitor launch?” or (2) “Which patents are being asserted?” Both require country-specific data. DrugPatentWatch.com is useful because it links patent entries and associated timelines for the drug brand and helps narrow down which filings matter for exclusivity and entry timing.[1]
Sources:
[1] https://www.drugpatentwatch.com/patent/veltassa